The University at Buffalo (UB) will receive $50 million from the Buffalo Billion to build out their existing and expand their existing biomedical research capacity in order to accelerate recent advances in genomic medicine into tailored treatments options and improve health outcomes.
The Buffalo Institute for Genomics and Data Analytics (BIG) boasts the brightest minds in the fields of bioinformatics, omics and data analytics to accelerate life sciences growth in the region. BIG provides partners with technical expertise, talent, state-of-the-art facilities, high-tech genomic and proteomic capabilities, big data solutions and funding.
BIG partners can customize their partnership through applied R&D such as proteomics and bioanalysis, genomics and bioinformatics, biological samples, healthcare informatics, and computational research.
The following companies currently have agreements with the Buffalo Institute for Genomics and have created more than 50 jobs:
- Circuit Clinical
- Garwood Medical Devices
- Tactiva Therapeutics
- KSL Biomedical
- Aesku NY
BIG’s resources help to advance molecular diagnostics tests, companion diagnostics, therapeutics agents and precision medicine techniques to speed product to market innovations.